Cite

HARVARD Citation

    Palacios, S. et al. (2022). Efficacy of low-dose vaginal 17β-estradiol versus vaginal promestriene for vulvovaginal atrophy. Climacteric. pp. 383-387. [Online]. 
  
Back to record